Thyroid Eye Disease: Incidence and Treatment

  Gary Joseph Lelli, MD, of the Department of Ophthalmology at Weill Cornell Medicine talks about the incidence and treatment options for thyroid eye disease due to Graves’ disease. Graves’ disease is an immune system disorder that results in the...

Ehlers-Danlos Syndrome: “It Hit Like a Tornado”

  Patricia Weltin of Beyond the Diagnosis talks about Elhers-Danlos syndrome, a rare disease that afflicts two of her daughters. Ehlers-Danlos syndrome is a group of connective tissue disorders. There are various forms of Ehlers-Danlos. According to the NIH,...

FDA Reviewing Drug Application for Neuromyelitis Optica

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application (BLA) for satralizumab to treat adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD). The FDA’s review will largely focus on two Phase III studies...

Thyroid Eye Disease: Diagnosis and Symptoms

  Gary Joseph Lelli, MD, of the Department of Ophthalmology at Weill Cornell Medicine talks about thyroid eye disease due to Graves’ disease, including which clinicians are most likely to diagnose this condition and the most common symptoms in this highly...

FDA Approves Landmark New Therapy for Cystic Fibrosis

The U.S. Food and Drug Administration has approved Vertex’s Trikafta (elexacaftor/ tezacaftor/ ivacaftor and ivacaftor) for the treating persons, 12 years and older, with cystic fibrosis who have at least one F508del mutation in the cystic fibrosis transmembrane...

FDA Approves New Complement Inhibitor for Patients With aHUS

The U.S. Food and Drug Adminstration (FDA) has approved Ultomiris (ravulizumab-cwvz) to treat adults and children (> 1 month of age) with atypical hemolytic uremic syndrome (aHUS). aHUS is an ultra-rare disease, characterized by inflammation and the formation of...
  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.